Neurochemistry international

Activation of a specific signaling pathway in the thinking areas of the brain distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor activators

Updated

Abstract

Hallucinogenic drugs activate both Gq/11 and Gi1 proteins through 5-HT2A receptors in the human brain.

  • Hallucinogenic 5-HT2A receptor agonists activate Gq/11 and Gi1 proteins, while non-hallucinogenic agonists only activate Gq/11 proteins.
  • The study utilized post-mortem human prefrontal cortex and confirmed findings using 5-HT2A receptor knock-out mouse brain tissue.
  • Activation of Gi1 proteins by hallucinogenic agonists may be linked to their psychedelic effects.
  • Other G protein types (G2, Go, Gs, and Gz) were activated by the agonists but through different receptor targets.
  • The alkylating agent NEM reduced agonist-mediated Gi1 protein activation without affecting Gq/11 protein activation.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free